An evidence-based approach to selected joint therapies in horses.
There is an enormous volume of published material about most of the agents used to treat or prevent arthritis in horses. Unfortunately, most of the claims made by nearly all purveyors of arthritis medications in such media are largely unsubstantiated. In addition, the quality of the available information is highly inconsistent, making evidence-based recommendations difficult. This article concentrates on injectable polysulfated glycosaminoglycan, injectable hyaluronan, and the common oral "nutraceuticals".
Richardson
Dean W
DW
University of Pennsylvania, School of Veterinary Medicine, New Bolton Center, Kennett Square, PA 19348-1692, USA. dwr@vet.upenn.edu <dwr@vet.upenn.edu>
Loinaz
Ricardo
R
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001168:Arthritis / Q000188:drug therapy / Q000517:prevention & control / Q000628:therapy / Q000662:veterinary*; D019317:Evidence-Based Medicine; D006025:Glycosaminoglycans / Q000627:therapeutic use; D006734:Horse Diseases / Q000188:drug therapy* / Q000517:prevention & control / Q000628:therapy; D006736:Horses; D006820:Hyaluronic Acid / Q000627:therapeutic use; D007592:Joint Diseases / Q000188:drug therapy / Q000628:therapy / Q000662:veterinary*; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D006025:Glycosaminoglycans; D006820:Hyaluronic Acid